American Journal of Obstetrics and Gynecology
ResearchObstetricsEvaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women
Section snippets
Materials and Methods
This was a prospective observational blinded study that involved a consecutive series of 300 symptomatic women with singleton pregnancies who underwent fFN sampling between 22+0 and 35+6 weeks' gestation for symptoms that are suggestive of threatened preterm labor. Such women had all presented themselves to an emergency assessment unit with symptoms of threatened preterm labor that the attending clinician believed warranted an fFN test. According to hospital protocol and the licensing
Results
Demographic and obstetrics characteristics for the study participants are described in Table 1. A total of 300 women with singleton pregnancies were eligible for analysis (21 women were removed according to the listed exclusion criteria; Figure 1). The mean gestational age of testing was 29+4 weeks' gestation (SD, 3.82 weeks), and 5.7% of the study population delivered spontaneously within 14 days of testing. There were no adverse events related to the test. Overall, there was a sPTB rate of
Comment
This is the first study, to our knowledge, to report the use of a novel bedside Rapid fFN 10Q system to quantify fFN concentrations within cervicovaginal fluid and to determine the subsequent risk of sPTB. The results clearly demonstrate that quantitative information has added value over the currently used qualitative fFN bedside test.
These data are supportive of previous reports from our group and others who reported improved prediction of preterm birth using values for the fFN concentration
Acknowledgments
We thank James T Kurtman (Loma Linda University, CA) and Manju Chandiramani (Imperial College, London) for their assistance in protocol development.
References (12)
- et al.
Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial
Am J Obstet Gynecol
(1997) - et al.
The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth: NICHD Network
Am J Obstet Gynecol
(2000) - et al.
Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women
Obstet Gynecol
(2001) - et al.
Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data
BMC Pregnancy Childbirth
(2010) - et al.
Frequency of uterine contractions and the risk of spontaneous preterm delivery
N Engl J Med
(2002) - et al.
An analysis of neonatal morbidity and mortality in maternal (in utero) and neonatal transports at 24-34 weeks' gestation
Am J Perinatol
(1997)
Cited by (107)
Systematic review of long QT syndrome identified during fetal life
2023, Heart RhythmThe use of fetal fibronectin and cervical length measurements in the prediction of spontaneous preterm birth in women with an Arabin pessary in situ
2022, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :The difference in predictive performance between the two groups could be explained by the technical difficulty of visualising the cervix after insertion of the probe to take an accurate measurement of CL with an Arabin pessary in situ. Previous studies have shown the efficacy of the use of fetal fibronectin in predicting spontaneous preterm birth in both asymptomatic and high risk symptomatic women [17]. A retrospective observational study in 2019 assessed qfFN readings in women with emergency insertion of a cervical cerclage, it showed a significant difference in women who delivered preterm compared to those who did not (p = 0.0048), confirming its role in predicting spontaneous preterm birth [18].
Predictive RNA profiles for early and very early spontaneous preterm birth
2022, American Journal of Obstetrics and GynecologyTen women's decision-making experiences in threatened preterm labour: Qualitative findings from the EQUIPTT trial
2021, Sexual and Reproductive HealthcareCervical length change as a predictor of preterm birth in symptomatic patients
2021, American Journal of Obstetrics and Gynecology MFM
Supported by Tommy's Baby Charity number 1060508; Wellbeing of Women Research Scholarship Charity number 239281; and minority financial and equipment assistance from Hologic USA (Marlborough, MA). D.S.A. and A.H.S. received financial assistance from Hologic USA for providing educational talks on preterm birth.
The authors report no conflict of interest.
Reprints not available from the authors.
Cite this article as: Abbott DS, Radford SK, Seed PT, et al. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol 2013;208:122.e1-6.